NYSE - Nasdaq Real Time Price USD

Houlihan Lokey, Inc. (HLI)

123.46 +1.08 (+0.88%)
As of 11:45 AM EDT. Market Open.

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 8888
Avg. Estimate 1.211.224.435.67
Low Estimate 1.081.014.35.04
High Estimate 1.321.334.546.11
Year Ago EPS 1.110.894.544.43

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 7688
Avg. Estimate 504.71M507.32M1.9B2.25B
Low Estimate 477M469.4M1.87B2.13B
High Estimate 532.5M535.09M1.93B2.38B
Year Ago Sales 444.77M434.84M1.81B1.9B
Sales Growth (year/est) 13.50%16.70%5.10%18.40%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. 0.931.011.031.14
EPS Actual 1.110.891.111.22
Difference 0.18-0.120.080.08
Surprise % 19.40%-11.90%7.80%7.00%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate 1.211.224.435.67
7 Days Ago 1.211.224.435.67
30 Days Ago 1.221.234.445.7
60 Days Ago 1.221.234.445.72
90 Days Ago 1.231.234.395.71

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days 1--1--
Up Last 30 Days 3233
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD HLIIndustrySectorS&P 500
Current Qtr. 9.00%----0.80%
Next Qtr. 37.10%----9.60%
Current Year -2.40%----4.50%
Next Year 28.00%----13.30%
Next 5 Years (per annum) 8.70%----11.09%
Past 5 Years (per annum) 11.22%------

Research Analysis

Analyst Price Targets

102.00 Low
132.80 Average
123.46 Current
151.00 High

Fair Value

Near Fair Value
% Return
123.46 Current
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Reiterates JMP Securities: Market Perform 4/9/2024
Maintains UBS: Buy to Buy 2/5/2024
Maintains UBS: Buy to Buy 2/2/2024
Maintains UBS: Buy to Buy 1/9/2024
Maintains UBS: Buy to Buy 10/3/2023
Maintains Morgan Stanley: Equal-Weight to Equal-Weight 7/12/2023

Related Tickers